The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential

被引:108
作者
Beltran, Himisha [1 ]
机构
[1] Weill Cornell Med Coll, New York, NY 10005 USA
关键词
IN-SITU HYBRIDIZATION; DEACETYLASE INHIBITOR BL1521; SMALL-MOLECULE INHIBITORS; SMALL-CELL-CARCINOMA; GENE AMPLIFICATION; C-MYC; DIFFERENTIAL EXPRESSION; ORNITHINE-DECARBOXYLASE; MALIGNANT PROGRESSION; EMBRYONIC LETHALITY;
D O I
10.1158/1541-7786.MCR-13-0536
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
N-myc (MYCN), a member of the Myc family of basic-helix-loop-helix-zipper (bHLHZ) transcription factors, is a central regulator of many vital cellular processes. As such, N-myc is well recognized for its classic oncogenic activity and association with human neuroblastoma. Amplification and overexpression of N-myc has been described in other tumor types, particularly those of neural origin and neuroendocrine tumors. This review outlines N-myc's contribution to normal development and oncogenic progression. In addition, it highlights relevant transcriptional targets and mechanisms of regulation. Finally, the clinical implications of N-Myc as a biomarker and potential as a target using novel therapeutic approaches are discussed. (C) 2014 AACR.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 95 条
  • [1] Alaminos M, 2003, CANCER RES, V63, P4538
  • [2] Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540
  • [3] Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
    Beltran, Himisha
    Rickman, David S.
    Park, Kyung
    Chae, Sung Suk
    Sboner, Andrea
    MacDonald, Theresa Y.
    Wang, Yuwei
    Sheikh, Karen L.
    Terry, Stephane
    Tagawa, Scott T.
    Dhir, Rajiv
    Nelson, Joel B.
    de la Taille, Alexandre
    Allory, Yves
    Gerstein, Mark B.
    Perner, Sven
    Pienta, Kenneth J.
    Chinnaiyan, Arul M.
    Wang, Yuzhuo
    Collins, Colin C.
    Gleave, Martin E.
    Demichelis, Francesca
    Nanus, David M.
    Rubin, Mark A.
    [J]. CANCER DISCOVERY, 2011, 1 (06) : 487 - 495
  • [4] Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
    Berwanger, B
    Hartmann, O
    Bergmann, E
    Bernard, S
    Nielsen, D
    Krause, M
    Kartal, A
    Flynn, D
    Wiedemeyer, R
    Schwab, M
    Schäfer, H
    Christiansen, H
    Eilers, M
    [J]. CANCER CELL, 2002, 2 (05) : 377 - 386
  • [5] Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
    Bjerke, Lynn
    Mackay, Alan
    Nandhabalan, Meera
    Burford, Anna
    Jury, Alexa
    Popov, Sergey
    Bax, Dorine A.
    Carvalho, Diana
    Taylor, Kathryn R.
    Vinci, Maria
    Bajrami, Ilirjana
    McGonnell, Imelda M.
    Lord, Christopher J.
    Reis, Rui M.
    Hargrave, Darren
    Ashworth, Alan
    Workman, Paul
    Jones, Chris
    [J]. CANCER DISCOVERY, 2013, 3 (05) : 512 - 519
  • [6] MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC
    BLACKWOOD, EM
    EISENMAN, RN
    [J]. SCIENCE, 1991, 251 (4998) : 1211 - 1217
  • [7] N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
    Boon, K
    Caron, HN
    van Asperen, R
    Valentijn, L
    Hermus, MC
    van Sluis, P
    Roobeek, I
    Weis, I
    Voûte, PA
    Schwab, M
    Versteeg, R
    [J]. EMBO JOURNAL, 2001, 20 (06) : 1383 - 1393
  • [8] Prognostic significance of MYCN oncogene expression in childhood neuroblastoma
    Bordow, SB
    Norris, MD
    Haber, PS
    Marshall, GM
    Haber, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3286 - 3294
  • [9] Myc represses transcription through recruitment of DNA methyltransferase corepressor
    Brenner, C
    Deplus, R
    Didelot, C
    Loriot, A
    Viré, E
    De Smet, C
    Gutierrez, A
    Danovi, D
    Bernard, D
    Boon, T
    Pelicci, PG
    Amati, B
    Kouzarides, T
    de Launoit, Y
    Di Croce, L
    Fuks, F
    [J]. EMBO JOURNAL, 2005, 24 (02) : 336 - 346
  • [10] Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
    Brockmann, Markus
    Poon, Evon
    Berry, Teeara
    Carstensen, Anne
    Deubzer, Hedwig E.
    Rycak, Lukas
    Jamin, Yann
    Thway, Khin
    Robinson, Simon P.
    Roels, Frederik
    Witt, Olaf
    Fischer, Matthias
    Chesler, Louis
    Eilers, Martin
    [J]. CANCER CELL, 2013, 24 (01) : 75 - 89